Category: Side Effect: Vision / Optical (blindness, macular edema, sudden vision loss)
-
Syfovre Eye Injury Cases: More Questions Than Answers One Year After First Reports
Retinal Vasculitis After Syfovre Injections: Etiology is Still Unknown and Incidence Rate Remains Unclear (Posted by Tom Lamb at Drug Injury Watch) Syfovre (pegcetacoplan) was approved by the FDA in February 2023 as an eye…
-
Syfovre Case Report: Occlusive Retinal Vasculitis Shortly After Patient’s First Syfovre Injection
Pre-Existing Allergy Toward Polyethylene Glycol (PEG) is Most Recent Causation Theory Offered by Apellis (Posted by Tom Lamb at Drug Injury Watch) In late January 2024, a leading medical journal for ophthalmologists and retina specialists,…
-
Syfovre Update: New Warnings About Retinal Vasculitis and/or Retinal Vascular Occlusion After Syfovre Injections
November 2023 Syfovre Label Change Comes After Earlier Reports of Eye Inflammation and Severe Vision Loss (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma news report, "Apellis cites…
-
Syfovre Patients Eye Side Effects Cases at Iowa Clinic: Important 2023 AAO Meeting Presentation
A Syfovre Case of Hemorrhagic Occlusive Vasculitis-type Inflammation With Continued Blindness Is Reported (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma news report, "Apellis cites current challenges with…
-
Eye Drug Syfovre Side Effects: Occlusive Retinal Vasculitis, Eye Inflammation, Vision Loss, And Blindness
American Society of Retinal Specialists (ASRS) July 2023 Warning Letter About Adverse Events Reports Associated With Syfovre (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma news report, "Apellis…
-
Beovu Drug Label Change in December 2021 Adds More Information About Vision Loss Side Effects
Provides "risk factors and possible mechanism" for Beovu-related Retinal Vasculitis and Retinal Vascular Occlusion (Posted by Tom Lamb at Drug Injury Watch) Update: "Novartis Finally Issues Revised Beovu Prescribing Information for US in February 2022"…
-
Beovu Safety Developments Presented by JAMA Ophthalmology Medical Journal in November 2021
Meanwhile, Still Waiting for the Anticipated Beovu Label Change That Was Previewed by Novartis Back in May 2021 (Posted by Tom Lamb at Drug Injury Watch) As the year 2021 draws to an end, we…
-
Elmiron and Maculopathy: Increased Risk of Ocular Complications in Long-Term, High-Dose Elmiron Use
Two Recent Medical Articles on Vision Side Effects of Elmiron (pentosan polysulfate sodium, or PPS) for Interstitial Cystitis (Posted by Tom Lamb at Drug Injury Watch) Chronic use of Elmiron (pentosan polysulfate sodium, or PPS)…